kneat.com,inc. Announces Appointment of United States Sales Director
HALIFAX, April 3, 2017 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat” or the “Company“) today announces the appointment of Mr. Derek Hughes in the role of United States Sales Director. Mr. Hughes will be responsible for sales of the Kneat.Gx software platform throughout the United States. Mr. Hughes joins the Kneat team after having spent the past six years successfully selling and promoting regulated software technologies into the life sciences industry throughout the United States. “The addition of Derek to our team will allow us to advance our sales strategy throughout North America”, said Eddie Ryan, Chief Executive Officer of Kneat. “The timing is right to ramp up our sales efforts in the United States in response to strong interest levels and a recent successful global deployment for one of our biotech customers who is achieving compelling compliance, productivity and time to market benefits.”
Kneat develops and markets the next generation Kneat Gx software platform. Kneat Gx is a systems lifecycle management solution which manages the full lifecycle from design through verification through ongoing change and final decommissioning. Our customers are streamlining all validations (process, equipment, computer, cleaning and laboratory), commissioning and qualification, product changeovers, vendor and project turnover management and more. For more information, please visit www.kneat.com.
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information, includes, but is not limited to, the ability to generate sales of the Kneat Gx platform, the ability to build relationships with current and prospective customers, the market potential for the Kneat Gx platform and the compliance of the Kneat Gx platform under regulatory audit and inspection. While such forward-looking statements are expressed by the Company, as stated in this release, in good faith and believed by the Company to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties. The Company does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor’s own risk.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information: